Latest News
AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer
...
Caliway to present preclinical data on CBL-514 in combination with GLP-1R therapy at ADA 2026 Scientific Sessions
2 April 2026 - Caliway Biopharmaceuticals (TWSE:6919), a Taiwan-based clinical-stage biopharmaceutical company, announced on Thursday that the latest preclinical data on its first-in-class large-area localised fat reduction drug candidate, CBL-514, i...
Mary's Medicinals to participate in CMS trial programme with cannabinoid-based wellness products
2 April 2026 - Denver-based Mary's Medicinals, a subsidiary of MM Brands Inc, announced on Wednesday its intent to participate in the newly established Centers for Medicare & Medicaid Services (CMS) cannabinoid therapy trial programme.Launch...
Lilly's Foundayo (orforglipron) weight loss pill gains US FDA approval
2 April 2026 - Pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Wednesday that the US Food and Drug Administration (FDA) has approved Foundayo (orforglipron) for adults with obesity, or overweight with weight-related medical probl...
Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development
1 April 2026 - Thermo Fisher Scientific Inc (NYSE: TMO) announced on Wednesday that it has unveiled its next-generation Gibco CHOvantage GS Cell Line Development (CLD) Kit, an integrated platform designed to accelerate biologics development while sup...